Global Bacillus Calmette Guerin Vaccine Market Growth 2022-2028
As the global economy mends, the 2021 growth of Bacillus Calmette Guerin Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Bacillus Calmette Guerin Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Bacillus Calmette Guerin Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Bacillus Calmette Guerin Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Bacillus Calmette Guerin Vaccine market, reaching US$ million by the year 2028. As for the Europe Bacillus Calmette Guerin Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Bacillus Calmette Guerin Vaccine players cover Merck, Sanofi Pasteur, Japan BCG Lab, and China National Biotec, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacillus Calmette Guerin Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Immune Type
Therapy Type
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bacillus Calmette Guerin Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bacillus Calmette Guerin Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bacillus Calmette Guerin Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Bacillus Calmette Guerin Vaccine Segment by Type
2.2.1 Immune Type
2.2.2 Therapy Type
2.3 Bacillus Calmette Guerin Vaccine Sales by Type
2.3.1 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Bacillus Calmette Guerin Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bacillus Calmette Guerin Vaccine Sale Price by Type (2017-2022)
2.4 Bacillus Calmette Guerin Vaccine Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Bacillus Calmette Guerin Vaccine Sales by Application
2.5.1 Global Bacillus Calmette Guerin Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Bacillus Calmette Guerin Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bacillus Calmette Guerin Vaccine Sale Price by Application (2017-2022)
3 Global Bacillus Calmette Guerin Vaccine by Company
3.1 Global Bacillus Calmette Guerin Vaccine Breakdown Data by Company
3.1.1 Global Bacillus Calmette Guerin Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Bacillus Calmette Guerin Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Bacillus Calmette Guerin Vaccine Revenue by Company (2020-2022)
3.2.2 Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Bacillus Calmette Guerin Vaccine Sale Price by Company
3.4 Key Manufacturers Bacillus Calmette Guerin Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bacillus Calmette Guerin Vaccine Product Location Distribution
3.4.2 Players Bacillus Calmette Guerin Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bacillus Calmette Guerin Vaccine by Geographic Region
4.1 World Historic Bacillus Calmette Guerin Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Bacillus Calmette Guerin Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bacillus Calmette Guerin Vaccine Annual Revenue by Geographic Region
4.2 World Historic Bacillus Calmette Guerin Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Bacillus Calmette Guerin Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bacillus Calmette Guerin Vaccine Annual Revenue by Country/Region
4.3 Americas Bacillus Calmette Guerin Vaccine Sales Growth
4.4 APAC Bacillus Calmette Guerin Vaccine Sales Growth
4.5 Europe Bacillus Calmette Guerin Vaccine Sales Growth
4.6 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Growth
5 Americas
5.1 Americas Bacillus Calmette Guerin Vaccine Sales by Country
5.1.1 Americas Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022)
5.1.2 Americas Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022)
5.2 Americas Bacillus Calmette Guerin Vaccine Sales by Type
5.3 Americas Bacillus Calmette Guerin Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacillus Calmette Guerin Vaccine Sales by Region
6.1.1 APAC Bacillus Calmette Guerin Vaccine Sales by Region (2017-2022)
6.1.2 APAC Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2022)
6.2 APAC Bacillus Calmette Guerin Vaccine Sales by Type
6.3 APAC Bacillus Calmette Guerin Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bacillus Calmette Guerin Vaccine by Country
7.1.1 Europe Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022)
7.1.2 Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022)
7.2 Europe Bacillus Calmette Guerin Vaccine Sales by Type
7.3 Europe Bacillus Calmette Guerin Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bacillus Calmette Guerin Vaccine by Country
8.1.1 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Type
8.3 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bacillus Calmette Guerin Vaccine
10.3 Manufacturing Process Analysis of Bacillus Calmette Guerin Vaccine
10.4 Industry Chain Structure of Bacillus Calmette Guerin Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bacillus Calmette Guerin Vaccine Distributors
11.3 Bacillus Calmette Guerin Vaccine Customer
12 World Forecast Review for Bacillus Calmette Guerin Vaccine by Geographic Region
12.1 Global Bacillus Calmette Guerin Vaccine Market Size Forecast by Region
12.1.1 Global Bacillus Calmette Guerin Vaccine Forecast by Region (2023-2028)
12.1.2 Global Bacillus Calmette Guerin Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bacillus Calmette Guerin Vaccine Forecast by Type
12.7 Global Bacillus Calmette Guerin Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Bacillus Calmette Guerin Vaccine Product Offered
13.1.3 Merck Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product Offered
13.2.3 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Lab
13.3.1 Japan BCG Lab Company Information
13.3.2 Japan BCG Lab Bacillus Calmette Guerin Vaccine Product Offered
13.3.3 Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Japan BCG Lab Main Business Overview
13.3.5 Japan BCG Lab Latest Developments
13.4 China National Biotec
13.4.1 China National Biotec Company Information
13.4.2 China National Biotec Bacillus Calmette Guerin Vaccine Product Offered
13.4.3 China National Biotec Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 China National Biotec Main Business Overview
13.4.5 China National Biotec Latest Developments
13.5 AJ Vaccines
13.5.1 AJ Vaccines Company Information
13.5.2 AJ Vaccines Bacillus Calmette Guerin Vaccine Product Offered
13.5.3 AJ Vaccines Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AJ Vaccines Main Business Overview
13.5.5 AJ Vaccines Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India Bacillus Calmette Guerin Vaccine Product Offered
13.6.3 Serum Institute of India Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
13.7 Intervax
13.7.1 Intervax Company Information
13.7.2 Intervax Bacillus Calmette Guerin Vaccine Product Offered
13.7.3 Intervax Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Intervax Main Business Overview
13.7.5 Intervax Latest Developments
13.8 GSBPL
13.8.1 GSBPL Company Information
13.8.2 GSBPL Bacillus Calmette Guerin Vaccine Product Offered
13.8.3 GSBPL Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GSBPL Main Business Overview
13.8.5 GSBPL Latest Developments
13.9 Statens Serum Institute
13.9.1 Statens Serum Institute Company Information
13.9.2 Statens Serum Institute Bacillus Calmette Guerin Vaccine Product Offered
13.9.3 Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Statens Serum Institute Main Business Overview
13.9.5 Statens Serum Institute Latest Developments
13.10 Biomed Lublin
13.10.1 Biomed Lublin Company Information
13.10.2 Biomed Lublin Bacillus Calmette Guerin Vaccine Product Offered
13.10.3 Biomed Lublin Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Biomed Lublin Main Business Overview
13.10.5 Biomed Lublin Latest Developments
13.11 ANLIS Malbran
13.11.1 ANLIS Malbran Company Information
13.11.2 ANLIS Malbran Bacillus Calmette Guerin Vaccine Product Offered
13.11.3 ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 ANLIS Malbran Main Business Overview
13.11.5 ANLIS Malbran Latest Developments
13.12 Fundação Ataulpho de Paiva
13.12.1 Fundação Ataulpho de Paiva Company Information
13.12.2 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product Offered
13.12.3 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Fundação Ataulpho de Paiva Main Business Overview
13.12.5 Fundação Ataulpho de Paiva Latest Developments
13.13 BB-NCIPD
13.13.1 BB-NCIPD Company Information
13.13.2 BB-NCIPD Bacillus Calmette Guerin Vaccine Product Offered
13.13.3 BB-NCIPD Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 BB-NCIPD Main Business Overview
13.13.5 BB-NCIPD Latest Developments
13.14 Taj Pharmaceuticals
13.14.1 Taj Pharmaceuticals Company Information
13.14.2 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product Offered
13.14.3 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Taj Pharmaceuticals Main Business Overview
13.14.5 Taj Pharmaceuticals Latest Developments
13.15 Bio Farma
13.15.1 Bio Farma Company Information
13.15.2 Bio Farma Bacillus Calmette Guerin Vaccine Product Offered
13.15.3 Bio Farma Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Bio Farma Main Business Overview
13.15.5 Bio Farma Latest Developments
13.16 Microgen
13.16.1 Microgen Company Information
13.16.2 Microgen Bacillus Calmette Guerin Vaccine Product Offered
13.16.3 Microgen Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Microgen Main Business Overview
13.16.5 Microgen Latest Developments
13.17 Torlakinstitut
13.17.1 Torlakinstitut Company Information
13.17.2 Torlakinstitut Bacillus Calmette Guerin Vaccine Product Offered
13.17.3 Torlakinstitut Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Torlakinstitut Main Business Overview
13.17.5 Torlakinstitut Latest Developments
13.18 Institut Pasteur de Tunis
13.18.1 Institut Pasteur de Tunis Company Information
13.18.2 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product Offered
13.18.3 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Institut Pasteur de Tunis Main Business Overview
13.18.5 Institut Pasteur de Tunis Latest Developments
13.19 IVAC
13.19.1 IVAC Company Information
13.19.2 IVAC Bacillus Calmette Guerin Vaccine Product Offered
13.19.3 IVAC Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 IVAC Main Business Overview
13.19.5 IVAC Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Bacillus Calmette Guerin Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bacillus Calmette Guerin Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Immune Type
Table 4. Major Players of Therapy Type
Table 5. Global Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Bacillus Calmette Guerin Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Bacillus Calmette Guerin Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Bacillus Calmette Guerin Vaccine Revenue by Application (2017-2022)
Table 13. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Bacillus Calmette Guerin Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Bacillus Calmette Guerin Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Bacillus Calmette Guerin Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Bacillus Calmette Guerin Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Bacillus Calmette Guerin Vaccine Producing Area Distribution and Sales Area
Table 21. Players Bacillus Calmette Guerin Vaccine Products Offered
Table 22. Bacillus Calmette Guerin Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bacillus Calmette Guerin Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Bacillus Calmette Guerin Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Bacillus Calmette Guerin Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Bacillus Calmette Guerin Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Bacillus Calmette Guerin Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Bacillus Calmette Guerin Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Bacillus Calmette Guerin Vaccine
Table 66. Key Market Challenges & Risks of Bacillus Calmette Guerin Vaccine
Table 67. Key Industry Trends of Bacillus Calmette Guerin Vaccine
Table 68. Bacillus Calmette Guerin Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Bacillus Calmette Guerin Vaccine Distributors List
Table 71. Bacillus Calmette Guerin Vaccine Customer List
Table 72. Global Bacillus Calmette Guerin Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Bacillus Calmette Guerin Vaccine Sales Market Forecast by Region
Table 74. Global Bacillus Calmette Guerin Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Bacillus Calmette Guerin Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Bacillus Calmette Guerin Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Bacillus Calmette Guerin Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Bacillus Calmette Guerin Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Bacillus Calmette Guerin Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Bacillus Calmette Guerin Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Bacillus Calmette Guerin Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Bacillus Calmette Guerin Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Bacillus Calmette Guerin Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Bacillus Calmette Guerin Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Bacillus Calmette Guerin Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Bacillus Calmette Guerin Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Bacillus Calmette Guerin Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Bacillus Calmette Guerin Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Bacillus Calmette Guerin Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Bacillus Calmette Guerin Vaccine Product Offered
Table 94. Merck Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Sanofi Pasteur Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product Offered
Table 99. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sanofi Pasteur Main Business
Table 101. Sanofi Pasteur Latest Developments
Table 102. Japan BCG Lab Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Japan BCG Lab Bacillus Calmette Guerin Vaccine Product Offered
Table 104. Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Japan BCG Lab Main Business
Table 106. Japan BCG Lab Latest Developments
Table 107. China National Biotec Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. China National Biotec Bacillus Calmette Guerin Vaccine Product Offered
Table 109. China National Biotec Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. China National Biotec Main Business
Table 111. China National Biotec Latest Developments
Table 112. AJ Vaccines Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. AJ Vaccines Bacillus Calmette Guerin Vaccine Product Offered
Table 114. AJ Vaccines Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. AJ Vaccines Main Business
Table 116. AJ Vaccines Latest Developments
Table 117. Serum Institute of India Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Serum Institute of India Bacillus Calmette Guerin Vaccine Product Offered
Table 119. Serum Institute of India Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Serum Institute of India Main Business
Table 121. Serum Institute of India Latest Developments
Table 122. Intervax Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Intervax Bacillus Calmette Guerin Vaccine Product Offered
Table 124. Intervax Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Intervax Main Business
Table 126. Intervax Latest Developments
Table 127. GSBPL Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. GSBPL Bacillus Calmette Guerin Vaccine Product Offered
Table 129. GSBPL Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. GSBPL Main Business
Table 131. GSBPL Latest Developments
Table 132. Statens Serum Institute Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Statens Serum Institute Bacillus Calmette Guerin Vaccine Product Offered
Table 134. Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Statens Serum Institute Main Business
Table 136. Statens Serum Institute Latest Developments
Table 137. Biomed Lublin Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Biomed Lublin Bacillus Calmette Guerin Vaccine Product Offered
Table 139. Biomed Lublin Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Biomed Lublin Main Business
Table 141. Biomed Lublin Latest Developments
Table 142. ANLIS Malbran Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. ANLIS Malbran Bacillus Calmette Guerin Vaccine Product Offered
Table 144. ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. ANLIS Malbran Main Business
Table 146. ANLIS Malbran Latest Developments
Table 147. Fundação Ataulpho de Paiva Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product Offered
Table 149. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Fundação Ataulpho de Paiva Main Business
Table 151. Fundação Ataulpho de Paiva Latest Developments
Table 152. BB-NCIPD Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. BB-NCIPD Bacillus Calmette Guerin Vaccine Product Offered
Table 154. BB-NCIPD Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. BB-NCIPD Main Business
Table 156. BB-NCIPD Latest Developments
Table 157. Taj Pharmaceuticals Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product Offered
Table 159. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Taj Pharmaceuticals Main Business
Table 161. Taj Pharmaceuticals Latest Developments
Table 162. Bio Farma Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. Bio Farma Bacillus Calmette Guerin Vaccine Product Offered
Table 164. Bio Farma Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Bio Farma Main Business
Table 166. Bio Farma Latest Developments
Table 167. Microgen Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 168. Microgen Bacillus Calmette Guerin Vaccine Product Offered
Table 169. Microgen Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Microgen Main Business
Table 171. Microgen Latest Developments
Table 172. Torlakinstitut Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 173. Torlakinstitut Bacillus Calmette Guerin Vaccine Product Offered
Table 174. Torlakinstitut Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Torlakinstitut Main Business
Table 176. Torlakinstitut Latest Developments
Table 177. Institut Pasteur de Tunis Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 178. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product Offered
Table 179. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Institut Pasteur de Tunis Main Business
Table 181. Institut Pasteur de Tunis Latest Developments
Table 182. IVAC Basic Information, Bacillus Calmette Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 183. IVAC Bacillus Calmette Guerin Vaccine Product Offered
Table 184. IVAC Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. IVAC Main Business
Table 186. IVAC Latest Developments
List of Figures
Figure 1. Picture of Bacillus Calmette Guerin Vaccine
Figure 2. Bacillus Calmette Guerin Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bacillus Calmette Guerin Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Bacillus Calmette Guerin Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bacillus Calmette Guerin Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Immune Type
Figure 10. Product Picture of Therapy Type
Figure 11. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type in 2021
Figure 12. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Bacillus Calmette Guerin Vaccine Consumed in Hospitals
Figure 14. Global Bacillus Calmette Guerin Vaccine Market: Hospitals (2017-2022) & (K Units)
Figure 15. Bacillus Calmette Guerin Vaccine Consumed in Clinics
Figure 16. Global Bacillus Calmette Guerin Vaccine Market: Clinics (2017-2022) & (K Units)
Figure 17. Bacillus Calmette Guerin Vaccine Consumed in Others
Figure 18. Global Bacillus Calmette Guerin Vaccine Market: Others (2017-2022) & (K Units)
Figure 19. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Application in 2021
Figure 21. Bacillus Calmette Guerin Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Company in 2021
Figure 23. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Bacillus Calmette Guerin Vaccine Sales 2017-2022 (K Units)
Figure 28. Americas Bacillus Calmette Guerin Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Bacillus Calmette Guerin Vaccine Sales 2017-2022 (K Units)
Figure 30. APAC Bacillus Calmette Guerin Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Bacillus Calmette Guerin Vaccine Sales 2017-2022 (K Units)
Figure 32. Europe Bacillus Calmette Guerin Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Bacillus Calmette Guerin Vaccine Sales Market Share by Country in 2021
Figure 36. Americas Bacillus Calmette Guerin Vaccine Revenue Market Share by Country in 2021
Figure 37. United States Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Bacillus Calmette Guerin Vaccine Sales Market Share by Region in 2021
Figure 42. APAC Bacillus Calmette Guerin Vaccine Revenue Market Share by Regions in 2021
Figure 43. China Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Bacillus Calmette Guerin Vaccine Sales Market Share by Country in 2021
Figure 50. Europe Bacillus Calmette Guerin Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Bacillus Calmette Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Bacillus Calmette Guerin Vaccine in 2021
Figure 64. Manufacturing Process Analysis of Bacillus Calmette Guerin Vaccine
Figure 65. Industry Chain Structure of Bacillus Calmette Guerin Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets